Women Health News
Categories
Recent
- 3 Cups of Coffee Safe for Pregnant Women’s
- Calcium is Important for Breast-feeding Moms
- Trans Fats may Increase Infertility Risk
- Dental X-rays: New way to Detect Bone-thinning Dis...
- Womb Transplants Might Become Reality
- Herbal Supplements No Help?
- Women Going off Menopause Hormones
- The Urgent of Cervical Cancer Vaccines
- Fewer Stress with Calcium and Vitamin D
- Hormone skin patches and Gels safer than pills
Links
Sponsor
Women Going off Menopause Hormones
SAN ANTONIO – The news that a big drop in breast cancer cases might be due to millions of women going off menopause hormones may lead even more of them to dump the pills.But doctors concern that women with strict menopausal symptoms will overreact to the risks and refuse themselves the benefits of hormones.
"There are some women who really require treatment. ... I worry that they will be talked out of it," said Dr. JoAnn Manson, a women's health expert at Harvard-affiliated Brigham and Women's Hospital in Boston.
Hormone use plummeted following a 2002 study found that it raised the risk of breast cancer, heart disease and other troubles. Before that, the pills were thought to avoid many of those conditions, and doctors prescribed them as little fountains of youth.
Researchers reported that the rate of breast cancer in the United States dropped over 7 percent in 2003, the year following that landmark study. The reaction against hormones is measured the leading details for the decline.
Some women are still with hormone therapy "because their doctors genuinely believe that it prevents some diseases," said Dr. Isaac Schiff of Massachusetts General Hospital, who headed a panel for the American College of Obstetricians and Gynecologists that recommended in 2004 that doctors not refuse to give the treatment from women who really need it.
But that's not as many women as you might think, Manson said.
About 2 million women begin menopause each year in the United States, but only about one-fourth have moderate to severe symptoms lasting longer than four years, said Manson, whose new book, "Hot Flashes, Hormones & Your Health," includes a flowchart to help women make a decision whether to use hormones, which type and for how long.
"There are some women who really require treatment. ... I worry that they will be talked out of it," said Dr. JoAnn Manson, a women's health expert at Harvard-affiliated Brigham and Women's Hospital in Boston.
Hormone use plummeted following a 2002 study found that it raised the risk of breast cancer, heart disease and other troubles. Before that, the pills were thought to avoid many of those conditions, and doctors prescribed them as little fountains of youth.
Researchers reported that the rate of breast cancer in the United States dropped over 7 percent in 2003, the year following that landmark study. The reaction against hormones is measured the leading details for the decline.
Some women are still with hormone therapy "because their doctors genuinely believe that it prevents some diseases," said Dr. Isaac Schiff of Massachusetts General Hospital, who headed a panel for the American College of Obstetricians and Gynecologists that recommended in 2004 that doctors not refuse to give the treatment from women who really need it.
But that's not as many women as you might think, Manson said.
About 2 million women begin menopause each year in the United States, but only about one-fourth have moderate to severe symptoms lasting longer than four years, said Manson, whose new book, "Hot Flashes, Hormones & Your Health," includes a flowchart to help women make a decision whether to use hormones, which type and for how long.
Labels: cancer, Menopauses
The Urgent of Cervical Cancer Vaccines
LONDON - International health experts called on Tuesday for rapid universal access to promising but expensive cervical cancer vaccines that have the prospective to save a quarter of a million lives a year.Merck & Co. Inc.’s lately launched Gardasil and GlaxoSmithKline Plc’s Cervarix, which is projected to be agreed next year, defend women against human papillomavirus (HPV), the virus that causes most cases of the disease.
They are likely to be embraced in wealthy countries but uptake in the developing world - where 80 percent of cervical cancer deaths happen - is uncertain, given their high price and latent resistance to vaccinating girls aged 9 to 13 years against the sexually transmitted virus.
The call for global access came at a conference in London getting together 60 health experts from multilateral agencies, government, charities and the drug industry.
“There is usually a 15 to 20 year delay between the time that new vaccines are accepted in the West and the time they arrive at developing countries,” said Nothemba Simelela of the International Planned Parenthood Federation.
“The world cannot afford to wait 20 years to begin saving women from cervical cancer.”
Death rates from the second most common female cancer are growing in the developing world, where more than 95 percent of women never have a cervical smear test.
They are likely to be embraced in wealthy countries but uptake in the developing world - where 80 percent of cervical cancer deaths happen - is uncertain, given their high price and latent resistance to vaccinating girls aged 9 to 13 years against the sexually transmitted virus.
The call for global access came at a conference in London getting together 60 health experts from multilateral agencies, government, charities and the drug industry.
“There is usually a 15 to 20 year delay between the time that new vaccines are accepted in the West and the time they arrive at developing countries,” said Nothemba Simelela of the International Planned Parenthood Federation.
“The world cannot afford to wait 20 years to begin saving women from cervical cancer.”
Death rates from the second most common female cancer are growing in the developing world, where more than 95 percent of women never have a cervical smear test.
Labels: cancer
© Health-Womens/ best in firefox
